Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
Authors
Lamarca, AngelaElliott, Emma
Barriuso, Jorge
Backen, Alison C
McNamara, Mairéad G
Hubner, Richard A
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2016-01-25
Metadata
Show full item recordAbstract
Chemotherapy is well-established in the treatment of patients with well-differentiated neuroendocrine tumours (NETs) arising from the pancreas (pNETs); however, its role in patients with gastrointestinal non-pancreatic NETs (non-pNETs) is uncertain. This systematic review assesses the evidence for the role of chemotherapy in well-differentiated non-pNET patients.Citation
Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause? 2016, 44:26-41 Cancer Treat RevJournal
Cancer Treatment ReviewsDOI
10.1016/j.ctrv.2016.01.005PubMed ID
26855376Type
ArticleLanguage
enISSN
1532-1967ae974a485f413a2113503eed53cd6c53
10.1016/j.ctrv.2016.01.005